Furthermore, knockout of SMAD3 in IPF cells by CRISPR-Cas9 genome editing suggests that TGFβ1 also utilises SMAD3 signalling for the upregulation of TG2. Here, SMAD3 is linked to idiopathic pulmonary fibrosis.